IGV tool advances for cancer genomics to help researchers and clinicians
Official title: The Integrative Genomics Viewer (IGV) for Cancer Research
Funded at University of California, San Diego · NIH-11603432 · Data updated 2026-11-12
A NIH grant supports keeping the Integrative Genomics Viewer (IGV) up-to-date so cancer researchers and clinicians can visualize and interpret complex genomic data more effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | September 7, 2021 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $680,127 |
| NIH project number | 3U24CA258406-05S1 |
| Project ID | NIH-11603432 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are patients whose cancer research or care involves analyzing tumor genomic data using IGV or similar visualization tools.
✕Less likely to help
Patients not involved in genomics analysis or not receiving care guided by tumor sequencing may not directly benefit.
What this research studies
This project keeps the IGV software current with new sequencing technologies and cancer-focused data types. It adds visuals and features to interpret both short and long DNA reads, and to better understand single nucleotide variants and structural changes. The tool is designed for everyday use by researchers and clinicians to help translate genomic data into cancer insights. Collaborations will bring new capabilities that align with evolving genomics methods and user needs.
Why it matters
Potential benefit: If successful, IGV will help cancer researchers and clinicians more accurately interpret genomic data to guide diagnosis and treatment decisions.
How similar studies have gone: IGV has been widely used since 2008, with ongoing updates showing sustained adoption in the research and clinical community.
Where this research is happening
-
University of California, San Diego
La Jolla, United States Active
Researchers
- Principal investigator: Mesirov, Jill P. — University of California, San Diego
- Study coordinator: Mesirov, Jill P.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.